Soluble Tumor Necrosis Factor Receptor 1 and 2 Predict Outcomes in Advanced Chronic Kidney Disease: A Prospective Cohort Study

by Neirynck, Nathalie, Glorieux, Griet, Schepers, Eva, Verbeke, Francis, Vanholder, Raymond
Published 2015

Response to Tsikas et al. Comments on Boelaert et al. Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC–MS/MS vers...

by Boelaert, Jente, Schepers, Eva, Glorieux, Griet, Eloot, Sunny, Vanholder, Raymond, Lynen, Frédéric
Published 2016

Determination of Asymmetric and Symmetric Dimethylarginine in Serum from Patients with Chronic Kidney Disease: UPLC-MS/MS versus ELISA

by Boelaert, Jente, Schepers, Eva, Glorieux, Griet, Eloot, Sunny, Vanholder, Raymond, Lynen, Frédéric
Published 2016

Does P-Cresylglucuronide Have the Same Impact on Mortality as Other Protein-Bound Uremic Toxins?

by Liabeuf, Sophie, Glorieux, Griet, Lenglet, Aurelie, Diouf, Momar, Schepers, Eva, Desjardins, Lucie, Choukroun, Gabriel, Vanholder, Raymond, Massy, Ziad A.
Published 2013

Transcriptome Analysis in Patients with Chronic Kidney Disease on Hemodialysis Disclosing a Key Role for CD16+CX3CR1+ Monocytes

by Schepers, Eva, Houthuys, Erica, Dhondt, Annemieke, De Meyer, Grim, Neirynck, Nathalie, Bernaert, Pascale, Van den Bergh, Rafael, Brouckaert, Peter, Vanholder, Raymond, Glorieux, Griet
Published 2015